COPD Exacerbation — Management

Key Points

• Do not assume every episode of dyspnea in COPD is an exacerbation; actively evaluate pneumonia, PE, heart failure, pneumothorax, and ACS.
• Use SABA with or without a short-acting anticholinergic for initial bronchodilation.
• A 5-day course of prednisone 40 mg daily is adequate for many adult exacerbations.
• Give antibiotics selectively, especially with purulent sputum plus other cardinal symptoms or need for ventilatory support.
• Target oxygen carefully, commonly 88% to 92% when hypercapnic respiratory failure is possible.
• NIV is preferred for acute hypercapnic respiratory acidosis when no contraindication is present.
• Sputum cultures are reserved for severe, recurrent, ventilated, or resistant-pathogen-risk presentations.
• Discharge planning should optimize maintenance inhalers, smoking cessation, vaccination, and pulmonary rehabilitation.

Algorithm

1. Assess work of breathing, oxygenation, mental status, hemodynamics, baseline oxygen use, and alternative diagnoses.
2. Give inhaled SABA and add ipratropium; titrate oxygen to an appropriate target.
3. Obtain chest imaging and blood gas when severity or differential diagnosis warrants it.
4. Start systemic corticosteroid and decide whether antibiotic criteria are met.
5. If hypercapnic respiratory acidosis or severe work of breathing is present, initiate NIV when appropriate and monitor closely.
6. Escalate to invasive ventilation for NIV failure, inability to protect airway, severe instability, or refractory gas-exchange failure.
7. As the patient improves, transition to long-acting inhaled maintenance therapy and address comorbid triggers.
8. Confirm discharge readiness, inhaler access and technique, oxygen needs, follow-up, and rehabilitation or cessation support.

Clinical Synopsis & Reasoning

COPD exacerbation is a clinical diagnosis of acutely worsened respiratory symptoms beyond usual day-to-day variation. Assess the severity of dyspnea, sputum volume and purulence, respiratory rate, oxygenation, mental status, hemodynamics, and baseline lung function or home oxygen use. Common triggers are viral respiratory infection, bacterial infection, air pollution, and medication nonadherence, but many apparent exacerbations are actually pneumonia, heart failure, pulmonary embolism, pneumothorax, arrhythmia, or acute coronary syndrome. Chest imaging is appropriate for hospitalized or moderate-to-severe presentations and when an alternative diagnosis is plausible. Measure blood gas when there is significant respiratory distress, altered mental status, severe hypoxemia, or concern for hypercapnia. An elevated PaCO2 may be chronic, so interpret pH and prior values. Sputum culture is not needed for every exacerbation but is useful in severe disease, frequent exacerbations, recent antibiotics, mechanical ventilation, or risk for resistant gram-negative organisms such as Pseudomonas. The 2026 GOLD report emphasizes SABA, with or without a short-acting anticholinergic, as initial bronchodilator therapy. Oxygen should be titrated rather than given indiscriminately because excessive oxygen can worsen hypercapnia in susceptible patients. The usual target saturation in patients at risk of hypercapnic respiratory failure is 88% to 92% pending blood gas assessment.

Treatment Strategy & Disposition

Give inhaled albuterol or another SABA promptly, with ipratropium added in moderate or severe exacerbations. Use metered-dose inhaler with spacer or nebulization according to severity and patient technique. Systemic corticosteroids shorten recovery and reduce treatment failure; prednisone 40 mg daily for 5 days is a widely used GOLD regimen. Antibiotics are indicated when bacterial infection is likely, particularly with increased sputum purulence plus increased dyspnea or sputum volume, and in patients requiring invasive or noninvasive mechanical ventilation. Choose the antibiotic according to local resistance, recent antibiotic exposure, allergy, exacerbation severity, and Pseudomonas risk, generally for about 5 days in uncomplicated responders. Titrate oxygen to the target range and obtain a blood gas when hypercapnia is possible. Noninvasive positive-pressure ventilation is first-line ventilatory support for appropriate patients with acute hypercapnic respiratory acidosis because it reduces intubation and mortality. Intubate when NIV is contraindicated or failing, airway protection is impaired, or instability is severe. Treat edema or heart failure when present, provide VTE prophylaxis to admitted immobile patients, and continue or restart long-acting maintenance inhalers as the patient stabilizes. Before discharge, reassess inhaler technique, smoking cessation, vaccinations, pulmonary rehabilitation eligibility, home oxygen criteria, and the chronic inhaled regimen.

Epidemiology / Risk Factors

• Respiratory viral infections are major triggers, with bacterial infection and environmental pollution also common.
• Prior exacerbations strongly predict future events and define a high-risk COPD phenotype.
• Active smoking accelerates lung-function decline and worsens exacerbation risk.
• Heart failure, ischemic heart disease, anxiety, malnutrition, and sleep-disordered breathing commonly complicate COPD care.
• Frequent antibiotic or hospital exposure increases the likelihood of resistant respiratory pathogens.

Investigations

Antibiotic Indications & Examples

Pharmacology

Prognosis / Complications

• Most mild exacerbations respond to outpatient therapy, while acute respiratory acidosis and need for ventilatory support predict higher mortality.
• Recovery of symptoms and exercise tolerance may take weeks even after gas exchange improves.
• Hospitalization for COPD exacerbation is a marker of increased risk for future admissions and death.
• Pulmonary rehabilitation after hospitalization can improve function and reduce rehospitalization in appropriate patients.
• Smoking cessation and optimized maintenance inhaled therapy have major long-term effects on symptoms and exacerbation frequency.

Patient Education / Counseling

• Demonstrate inhaler technique and confirm that the maintenance inhalers are affordable and available.
• Explain the oxygen target if home oxygen or chronic hypercapnia is present so the patient does not self-escalate oxygen without guidance.
• Encourage smoking cessation and offer pharmacologic and behavioral support.
• Review influenza, pneumococcal, COVID-19, and other indicated vaccinations.
• Seek urgent care for severe breathlessness at rest, confusion, cyanosis, chest pain, inability to eat or drink, or failure of rescue inhalers.

Notes

The key safety issue in severe COPD exacerbation is recognizing ventilatory failure before exhaustion becomes irreversible. Rising carbon dioxide with acidemia, worsening mental status, or sustained work of breathing should prompt early NIV in an appropriate patient. Oxygen is necessary when hypoxemic, but more is not always better; titrate to the target and recheck blood gas when hypercapnia is a concern. Before discharge, use the exacerbation as an opportunity to improve the long-term trajectory through smoking cessation, inhaler optimization, vaccination, pulmonary rehabilitation, and follow-up after a high-risk event.

References

1. GOLD 2026 Report and Pocket Guide — Link